{"id":109087,"date":"2021-05-30T08:36:41","date_gmt":"2021-05-30T08:36:41","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=109087"},"modified":"2023-06-18T06:15:14","modified_gmt":"2023-06-18T06:15:14","slug":"type-2-neurofibromatosis","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/type-2-neurofibromatosis\/","title":{"rendered":"Type 2 neurofibromatosis"},"content":{"rendered":"<p>Neurofibromatosis Type 2 (NF-2) is a less common type of neurofibromatosis. Neurofibromatoses are genetically transmitted disorders of the nervous system that often have an autosomal dominant pattern of transmission. These disorders may cause tumor growth on nerves and other abnormalities, such as multiple skin changes (e.g., cafe au lait spots) and bone deformities (National Institute of Neurological Disorders and Strokes [NINDS], 2001). Neurofibromatosis Type 1 (NF-1) is the more common type of neurofibromatosis.<\/p>\n<hr \/>\n<div class=\"group w-full text-gray-800 dark:text-gray-100 border-b border-black\/10 dark:border-gray-900\/50 bg-gray-50 dark:bg-[#444654] sm:AIPRM__conversation__response\">\n<div class=\"flex p-4 gap-4 text-base md:gap-6 md:max-w-2xl lg:max-w-[38rem] xl:max-w-3xl md:py-6 lg:px-0 m-auto\">\n<div class=\"relative flex w-[calc(100%-50px)] flex-col gap-1 md:gap-3 lg:w-[calc(100%-115px)]\">\n<div class=\"flex flex-grow flex-col gap-3\">\n<div class=\"min-h-[20px] flex flex-col items-start gap-4 whitespace-pre-wrap break-words\">\n<div class=\"markdown prose w-full break-words dark:prose-invert light AIPRM__conversation__response\">\n<p>An inheritable ailment linked to a heightened susceptibility to bilateral acoustic neuromas, along with additional tumors affecting nerve cells, as well as the development of cataracts.<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Neurofibromatosis Type 2 (NF-2) is a less common type of neurofibromatosis. Neurofibromatoses are genetically transmitted disorders of the nervous system that often have an autosomal dominant pattern of transmission. These disorders may cause tumor growth on nerves and other abnormalities, such as multiple skin changes (e.g., cafe au lait spots) and bone deformities (National Institute [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-109087","post","type-post","status-publish","format-standard","hentry","category-t"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Type 2 neurofibromatosis - Definition of Type 2 neurofibromatosis<\/title>\n<meta name=\"description\" content=\"Neurofibromatosis Type 2 (NF-2) is a less common type of neurofibromatosis. Neurofibromatoses are genetically transmitted disorders of the nervous system that often have an autosomal dominant pattern of transmission. These disorders may cause tumor growth on nerves and other abnormalities, such as multiple skin changes (e.g., cafe au lait spots) and bone deformities (National Institute of Neurological Disorders and Strokes [NINDS], 2001). Neurofibromatosis Type 1 (NF-1) is the more common type of neurofibromatosis.An inheritable ailment linked to a heightened susceptibility to bilateral acoustic neuromas, along with additional tumors affecting nerve cells, as well as the development of cataracts.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/type-2-neurofibromatosis\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Type 2 neurofibromatosis - Definition of Type 2 neurofibromatosis\" \/>\n<meta property=\"og:description\" content=\"Neurofibromatosis Type 2 (NF-2) is a less common type of neurofibromatosis. Neurofibromatoses are genetically transmitted disorders of the nervous system that often have an autosomal dominant pattern of transmission. These disorders may cause tumor growth on nerves and other abnormalities, such as multiple skin changes (e.g., cafe au lait spots) and bone deformities (National Institute of Neurological Disorders and Strokes [NINDS], 2001). Neurofibromatosis Type 1 (NF-1) is the more common type of neurofibromatosis.An inheritable ailment linked to a heightened susceptibility to bilateral acoustic neuromas, along with additional tumors affecting nerve cells, as well as the development of cataracts.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/type-2-neurofibromatosis\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-30T08:36:41+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-18T06:15:14+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/type-2-neurofibromatosis\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/type-2-neurofibromatosis\/\",\"name\":\"Type 2 neurofibromatosis - Definition of Type 2 neurofibromatosis\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2021-05-30T08:36:41+00:00\",\"dateModified\":\"2023-06-18T06:15:14+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"Neurofibromatosis Type 2 (NF-2) is a less common type of neurofibromatosis. Neurofibromatoses are genetically transmitted disorders of the nervous system that often have an autosomal dominant pattern of transmission. These disorders may cause tumor growth on nerves and other abnormalities, such as multiple skin changes (e.g., cafe au lait spots) and bone deformities (National Institute of Neurological Disorders and Strokes [NINDS], 2001). Neurofibromatosis Type 1 (NF-1) is the more common type of neurofibromatosis.An inheritable ailment linked to a heightened susceptibility to bilateral acoustic neuromas, along with additional tumors affecting nerve cells, as well as the development of cataracts.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/type-2-neurofibromatosis\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/type-2-neurofibromatosis\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/type-2-neurofibromatosis\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Type 2 neurofibromatosis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Type 2 neurofibromatosis - Definition of Type 2 neurofibromatosis","description":"Neurofibromatosis Type 2 (NF-2) is a less common type of neurofibromatosis. Neurofibromatoses are genetically transmitted disorders of the nervous system that often have an autosomal dominant pattern of transmission. These disorders may cause tumor growth on nerves and other abnormalities, such as multiple skin changes (e.g., cafe au lait spots) and bone deformities (National Institute of Neurological Disorders and Strokes [NINDS], 2001). Neurofibromatosis Type 1 (NF-1) is the more common type of neurofibromatosis.An inheritable ailment linked to a heightened susceptibility to bilateral acoustic neuromas, along with additional tumors affecting nerve cells, as well as the development of cataracts.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/type-2-neurofibromatosis\/","og_locale":"en_US","og_type":"article","og_title":"Type 2 neurofibromatosis - Definition of Type 2 neurofibromatosis","og_description":"Neurofibromatosis Type 2 (NF-2) is a less common type of neurofibromatosis. Neurofibromatoses are genetically transmitted disorders of the nervous system that often have an autosomal dominant pattern of transmission. These disorders may cause tumor growth on nerves and other abnormalities, such as multiple skin changes (e.g., cafe au lait spots) and bone deformities (National Institute of Neurological Disorders and Strokes [NINDS], 2001). Neurofibromatosis Type 1 (NF-1) is the more common type of neurofibromatosis.An inheritable ailment linked to a heightened susceptibility to bilateral acoustic neuromas, along with additional tumors affecting nerve cells, as well as the development of cataracts.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/type-2-neurofibromatosis\/","og_site_name":"Glossary","article_published_time":"2021-05-30T08:36:41+00:00","article_modified_time":"2023-06-18T06:15:14+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/type-2-neurofibromatosis\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/type-2-neurofibromatosis\/","name":"Type 2 neurofibromatosis - Definition of Type 2 neurofibromatosis","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2021-05-30T08:36:41+00:00","dateModified":"2023-06-18T06:15:14+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"Neurofibromatosis Type 2 (NF-2) is a less common type of neurofibromatosis. Neurofibromatoses are genetically transmitted disorders of the nervous system that often have an autosomal dominant pattern of transmission. These disorders may cause tumor growth on nerves and other abnormalities, such as multiple skin changes (e.g., cafe au lait spots) and bone deformities (National Institute of Neurological Disorders and Strokes [NINDS], 2001). Neurofibromatosis Type 1 (NF-1) is the more common type of neurofibromatosis.An inheritable ailment linked to a heightened susceptibility to bilateral acoustic neuromas, along with additional tumors affecting nerve cells, as well as the development of cataracts.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/type-2-neurofibromatosis\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/type-2-neurofibromatosis\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/type-2-neurofibromatosis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Type 2 neurofibromatosis"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/109087","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=109087"}],"version-history":[{"count":3,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/109087\/revisions"}],"predecessor-version":[{"id":229918,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/109087\/revisions\/229918"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=109087"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=109087"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=109087"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}